SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
- Conditions
- Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8
- Interventions
- Drug: ChemotherapyOther: Functional AssessmentOther: Questionnaire Administration
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1336
- Registration Number
- NCT03939481
- Locations
- 🇺🇸
University of Virginia Cancer Center, Charlottesville, Virginia, United States
🇺🇸Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States
🇺🇸Maine Medical Center- Scarborough Campus, Scarborough, Maine, United States
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
- Conditions
- Hepatitis B InfectionMalignant Solid Neoplasm
- Interventions
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 4
- Registration Number
- NCT03887702
- Locations
- 🇺🇸
Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States
🇺🇸M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸Health Partners Inc, Minneapolis, Minnesota, United States
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
- Conditions
- Previously Treated Non-Small Cell Lung Cancer
- Interventions
- Drug: Screening Platform
- First Posted Date
- 2019-02-22
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 10000
- Registration Number
- NCT03851445
- Locations
- 🇺🇸
Veterans Administration Medical Center - Birmingham, Birmingham, Alabama, United States
🇺🇸University of South Alabama Mitchell Cancer Institute, Mobile, Alabama, United States
🇺🇸Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)
- Conditions
- Deleterious BRCA1 Gene MutationRecurrent Large Cell Lung CarcinomaDeleterious BRCA2 Gene MutationRecurrent Lung AdenocarcinomaRecurrent Non-Squamous Non-Small Cell Lung CarcinomaStage IV Lung Cancer AJCC v8Loss of HeterozygosityLung Non-Small Cell Squamous CarcinomaStage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
- Interventions
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 64
- Registration Number
- NCT03845296
- Locations
- 🇺🇸
Mount Carmel East Hospital, Columbus, Ohio, United States
🇺🇸Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
🇺🇸Grady Health System, Atlanta, Georgia, United States
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
- Conditions
- Stage IIIA Distal Bile Duct Cancer AJCC v8Stage IIIB Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Gallbladder Cancer AJCC v8Unresectable Extrahepatic Bile Duct CarcinomaStage III Gallbladder Cancer AJCC v8Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8Stage IVA Gallbladder Cancer AJCC v8Unresectable Gallbladder CarcinomaUnresectable Intrahepatic Cholangiocarcinoma
- Interventions
- First Posted Date
- 2018-12-07
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 452
- Registration Number
- NCT03768414
- Locations
- 🇺🇸
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
🇺🇸Mountain Blue Cancer Care Center, Golden, Colorado, United States
🇺🇸Rocky Mountain Cancer Centers-Lakewood, Lakewood, Colorado, United States
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery
- Conditions
- Bladder Carcinoma
- Interventions
- Other: Laboratory Biomarker AnalysisDietary Supplement: Nutritional InterventionOther: Placebo AdministrationOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 203
- Registration Number
- NCT03757949
- Locations
- 🇺🇸
Maine Medical Center-Bramhall Campus, Portland, Maine, United States
🇺🇸Saint Joseph Mercy Brighton, Brighton, Michigan, United States
🇺🇸IHA Hematology Oncology Consultants-Canton, Canton, Michigan, United States
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- Conditions
- Progesterone Receptor PositiveEstrogen Receptor PositiveHER2/Neu NegativeElevated CA15-3 or CEA or CA27-29Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
- Interventions
- Other: Serum Tumor Marker directed disease monitoringOther: Usual care disease monitoringOther: Quality-of-Life AssessmentOther: Anxiety Questionnaire Administration
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 739
- Registration Number
- NCT03723928
- Locations
- 🇺🇸
Contra Costa Regional Medical Center, Martinez, California, United States
🇺🇸Kaiser Permanente-Riverside, Riverside, California, United States
🇺🇸Saint Mary Corwin Medical Center, Pueblo, Colorado, United States
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery
- Conditions
- Locally Advanced Thymic CarcinomaMetastatic Thymic CarcinomaRecurrent Thymic CarcinomaUnresectable Thymic Carcinoma
- Interventions
- First Posted Date
- 2018-10-03
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 21
- Registration Number
- NCT03694002
- Locations
- 🇺🇸
Benefis Healthcare- Sletten Cancer Institute, Great Falls, Montana, United States
🇺🇸Mercy Medical Center, Durango, Colorado, United States
🇺🇸Southwest Oncology PC, Durango, Colorado, United States
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Conditions
- Castration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
- Interventions
- Procedure: OrchiectomyOther: Quality-of-Life AssessmentRadiation: Radiation TherapyProcedure: Radical Prostatectomy
- First Posted Date
- 2018-09-19
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1273
- Registration Number
- NCT03678025
- Locations
- 🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Parkland Memorial Hospital, Dallas, Texas, United States
🇺🇸UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States
Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
- Conditions
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Interventions
- Other: Laboratory Biomarker Analysis
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 84
- Registration Number
- NCT03654768
- Locations
- 🇺🇸
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
🇺🇸Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
🇺🇸Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States